AI-generated summary
The authors prospectively studied 58 patients after carpal tunnel release, randomly assigned to low-level laser therapy at 830 nm or placebo. They report fewer postoperative complaints and fewer electromyographic abnormalities at six months in the laser group than in the placebo group. The abstract describes this as an initial study.
- Participants
- 58
- Who or what was studied
- Patients with carpal tunnel syndrome undergoing carpal tunnel release surgery
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract describes this as an initial study, and its reported results are limited to comparisons of group-level complaints and electromyographic findings without stated effect sizes or statistical tests.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Power
- 30 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.